ATTAIN-1 is the second trial this year to show positive results with once-daily orforglipron, with best results seen at the ...

In-store opportunities for patients to check in with their health may offer touchpoints to those who don’t regularly seek ...

Access to rehabilitation is a “lifeline” for patients that needs to be protected and preserved to ensure their recovery.

The document was designed to promote standardization and identify future research goals in this rapidly-growing field.

The US Food and Drug Administration approved the revised label for inclisiran, a small interfering RNA that reduces the ...

Boston Scientific is recommending updates to the instructions for use to minimize the issue, which has been tied to 17 deaths ...

When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.

A new meta-analysis lends support to the idea, but researchers caution many specifics must still be worked out.

This meta-analysis challenges the randomized FRAIL-AF results, but caution is needed when reconciling the discrepant findings ...

Clinical trials face challenges with variability in echo images, protocol adherence, and data quality. This discussion ...

In anthropometric testing, the head of the bed and nursing positions received less scatter with the EggNest versus Rampart.